SHARON SHAJI: Open Payments
NPI 1427886456 · SUNNYVALE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $50 |
| ABBVIE INC. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| SCILEX PHARMACEUTICALS INC. | 2 | $29 |
| Exact Sciences Corporation | 2 | $28 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, VRAYLAR, Symbravo, ELYXYB - CELECOXIB, Cologuard Collection Kit, GARDASIL 9, MOUNJARO, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
